American Century Companies’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

American Century Companies’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-134,449	Closed	-$8.04M	–	1889
2020 Q2	$8.04M	Buy	134,449 +44,214	+49%	+$2.73M	0.01%	719
2020 Q1	$5.36M	Sell	90,235 -41,339	-31%	-$2.41M	0.01%	717
2019 Q4	$7.21M	Sell	131,574 -4,898	-4%	-$183K	0.01%	750
2019 Q3	$3.85M	Buy	136,472 +53,520	+65%	+$1.96M	﹤0.01%	853
2019 Q2	$2.75M	Buy	82,952 +3,988	+5%	+$124K	﹤0.01%	973
2019 Q1	$2.69M	Sell	78,964 -7,713	-9%	-$245K	﹤0.01%	950
2018 Q4	$2.37M	Sell	86,677 -11,095	-11%	-$286K	﹤0.01%	940
2018 Q3	$2.86M	Buy	+97,772	New	+$2.76M	﹤0.01%	966

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

American Century Companies's PRNB Position: Q3 2020 in Review

American Century Companies sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 134,449 shares — an estimated $8.04M sold.

American Century Companies first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $8.04M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

American Century Companies reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
American Century Companies sold 134,449 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $8.04M.
American Century Companies first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
American Century Companies's Principia Biopharma Inc. Common Stock position peaked at $8.04M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on American Century Companies's 13F filing for Q3 2020, filed 13 Nov 2020.